XML 41 R29.htm IDEA: XBRL DOCUMENT
v3.21.2

SEGMENTS (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2021
SEGMENTS [Abstract] |
Summarized Financial Information Concerning Reportable Segments | Summarized financial information concerning reportable segments is shown in the following tables:
Three Months Ended June 30, 2021 |
|  | ADMA BioManufacturing |  |  | Plasma Collection Centers |  |  | Corporate |  |  | Consolidated |
Revenues |  | $ | 16,347,880 |  |  | $ | 1,447,001 |  |  | $ | 35,709 |  |  | $ | 17,830,590 |
Cost of product revenue |  |  | 17,382,292 |  |  |  | 1,450,332 |  |  |  | - |  |  |  | 18,832,624 |
Loss from operations |  |  | (8,337,405 | ) |  |  | (2,794,219 | ) |  |  | (4,449,608 | ) |  |  | (15,581,232 | )
Interest and other expense, net |  |  | (78,793 | ) |  |  | (366 | ) |  |  | (3,244,912 | ) |  |  | (3,324,071 | )
Net loss |  |  | (8,416,198 | ) |  |  | (2,794,585 | ) |  |  | (7,694,520 | ) |  |  | (18,905,303 | )
Depreciation and amortization expense |  |  | 1,055,537 |  |  |  | 268,927 |  |  |  | 1,530 |  |  |  | 1,325,994 |
Total assets |  |  | 169,799,509 |  |  |  | 20,593,411 |  |  |  | 42,420,872 |  |  |  | 232,813,792 |
Three Months Ended June 30, 2020 |
|  | ADMA BioManufacturing |  |  | Plasma Collection Centers |  |  | Corporate |  |  | Consolidated |
Revenues |  | $ | 6,502,865 |  |  | $ | 1,249,020 |  |  | $ | 35,709 |  |  | $ | 7,787,594 |
Cost of product revenue |  |  | 12,237,141 |  |  |  | 1,258,488 |  |  |  | - |  |  |  | 13,495,629 |
Loss from operations |  |  | (12,852,835 | ) |  |  | (919,309 | ) |  |  | (3,351,681 | ) |  |  | (17,123,825 | )
Interest and other expense, net |  |  | (235,442 | ) |  |  | (33 | ) |  |  | (2,818,791 | ) |  |  | (3,054,266 | )
Net loss |  |  | (13,088,277 | ) |  |  | (919,342 | ) |  |  | (6,170,472 | ) |  |  | (20,178,091 | )
Depreciation and amortization expense |  |  | 772,241 |  |  |  | 111,106 |  |  |  | 2,305 |  |  |  | 885,652 |
Total assets |  |  | 109,105,418 |  |  |  | 7,542,486 |  |  |  | 74,893,664 |  |  |  | 191,541,568 |
Six Months Ended June 30, 2021 |
|  | ADMA BioManufacturing |  |  | Plasma Collection Centers |  |  | Corporate |  |  | Consolidated |
Revenues |  | $ | 29,768,923 |  |  | $ | 4,038,868 |  |  | $ | 71,417 |  |  | $ | 33,879,208 |
Cost of product revenue |  |  | 32,832,049 |  |  |  | 3,770,697 |  |  |  | - |  |  |  | 36,602,746 |
Loss from operations |  |  | (17,843,093 | ) |  |  | (4,765,060 | ) |  |  | (8,137,328 | ) |  |  | (30,745,481 | )
Interest and other expense, net |  |  | (100,307 | ) |  |  | (750 | ) |  |  | (6,438,706 | ) |  |  | (6,539,763 | )
Net loss |  |  | (17,943,400 | ) |  |  | (4,765,810 | ) |  |  | (14,576,034 | ) |  |  | (37,285,244 | )
Capital expenditures |  |  | 2,725,432 |  |  |  | 4,321,303 |  |  |  | - |  |  |  | 7,046,735 |
Depreciation and amortization expense |  |  | 2,065,307 |  |  |  | 486,918 |  |  |  | 3,397 |  |  |  | 2,555,622 |
Six Months Ended June 30, 2020 |
|  | ADMA BioManufacturing |  |  | Plasma Collection Centers |  |  | Corporate |  |  | Consolidated |
Revenues |  | $ | 14,246,139 |  |  | $ | 3,669,782 |  |  | $ | 71,417 |  |  | $ | 17,987,338 |
Cost of product revenue |  |  | 26,689,094 |  |  |  | 3,635,761 |  |  |  | - |  |  |  | 30,324,855 |
Loss from operations |  |  | (25,328,980 | ) |  |  | (1,376,464 | ) |  |  | (7,188,167 | ) |  |  | (33,893,611 | )
Interest and other expense, net |  |  | (474,314 | ) |  |  | (33 | ) |  |  | (5,055,363 | ) |  |  | (5,529,710 | )
Net loss |  |  | (25,803,294 | ) |  |  | (1,376,497 | ) |  |  | (12,243,530 | ) |  |  | (39,423,321 | )
Capital expenditures |  |  | 5,064,494 |  |  |  | 1,178,790 |  |  |  | - |  |  |  | 6,243,284 |
Depreciation and amortization expense |  |  | 1,447,214 |  |  |  | 222,395 |  |  |  | 4,881 |  |  |  | 1,674,490 |
Net Revenues According to Geographic Area | Net revenues according to geographic area, based on the location of where the product is shipped, is as follows:
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |
United States |  | $ | 15,424,839 |  |  | $ | 6,797,170 |  |  | $ | 29,102,848 |  |  | $ | 15,453,443 |
International |  |  | 2,405,751 |  |  |  | 990,424 |  |  |  | 4,776,360 |  |  |  | 2,533,895 |
Total revenues |  | $ | 17,830,590 |  |  | $ | 7,787,594 |  |  | $ | 33,879,208 |  |  | $ | 17,987,338 |

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph a -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration